tiprankstipranks
Bristol-Myers Squibb (BMY)
NYSE:BMY

Bristol-Myers Squibb (BMY) Cash flow

10,019 Followers

Bristol-Myers Squibb Cash Flow

BMY's free cash flow for Q4 2023 was $3.92B. For the 2023 fiscal year, BMY's free cash flow was decreased by $694.00M and operating cash flow was $4.25B. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 13.86B$ 13.86B$ 13.07B$ 16.75B$ 14.05B$ 8.21B
Investing Cash Flow
$ -2.29B$ -2.29B$ -1.07B$ -1.08B$ -10.86B$ -9.91B
Financing Cash Flow
$ -9.42B$ -9.42B$ -16.96B$ -16.22B$ -1.15B$ 7.62B
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 36.52B$ 11.52B$ 9.32B$ 14.32B$ 14.97B$ 12.82B
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
------
Issuance Of Debt
$ 456.00M$ 456.00M$ -5.31B$ -6.18B$ 6.95B$ 26.78B
Repayment Of Debt
$ -3.64B$ -3.88B$ -11.43B$ -6.02B$ -2.75B$ -9.26B
Free Cash Flow
$ 12.65B$ 12.65B$ 11.96B$ 15.78B$ 13.30B$ 7.37B
Domestic Sales
------
Foreign Sales
------
Currency in USD

Bristol-Myers Squibb Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis